Related Experiment Videos
[Prognostic value of early coronary patency]
1Divisione di Cardiologia, Ospedale V Cervello, Palmero.
Insights
Promptly opening blocked arteries after heart attacks improves survival. The GUSTO trial confirmed the early-open artery hypothesis, showing faster, complete reperfusion with accelerated tissue plasminogen activator (rt-PA) significantly reduces mortality.
Area of Science:
- Cardiology
- Vascular Biology
- Emergency Medicine
Context:
- The "early-open artery hypothesis" posits that rapid reperfusion of ischemic heart muscle after acute myocardial infarction (AMI) improves outcomes.
- Previous trials (GISSI-2, ISIS-3) yielded conflicting results, questioning the hypothesis despite rt-PA's superior artery-opening efficacy over streptokinase.
Purpose:
- To re-evaluate the "early-open artery hypothesis" in the context of acute myocardial infarction management.
- To assess the impact of reperfusion speed and completeness on patient survival.
Summary:
- The GUSTO trial demonstrated that achieving early, rapid, and complete arterial patency (TIMI grade 3) via accelerated rt-PA administration significantly improves survival in AMI patients.
- This contrasts with earlier trials where traditional rt-PA administration failed to achieve optimal reperfusion, thus obscuring the benefits of the early-open artery strategy.
Impact:
- Restores the validity of the "early-open artery hypothesis" in clinical practice.
- Highlights the critical importance of timely and effective reperfusion strategies in improving survival rates for acute myocardial infarction.
- Informs guidelines for optimal thrombolytic therapy administration in AMI.
Abstract:
According the early-open artery hypothesis, a prompt reperfusion of the ischemic zone in evolving acute myocardial infarction leads to a relevant myocardial salvage with consequent reduction in mortality. This conception has been shaken by the results of GISSI-2 and ISIS-3 trials, in which the same survival was observed in patients treated with either streptokinase or rt-PA, in spite of the well known superiority of rt-PA over streptokinase in reopening the culprit artery. Recently the results of the GUSTO trial have restored the validity of the early-open artery hypothesis. This study shows that a better arterial patency does in fact produce a better survival, provided that thrombolysis is administered very early and reperfusion is fast (with "accelerated" rt-PA) and quite complete (TIMI grade 3), goals not achieved in GISSI-2 and ISIS-3 because in these studies rt-PA was administered in the traditional, not accelerated, way.